Suppr超能文献

蛋白酶体激活剂 Blm10/PA200 增强了 N 端 Huntingtin 的蛋白酶体降解。

The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin.

机构信息

Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

Doctoral School of Molecular Medicine, University of Debrecen, 4032 Debrecen, Hungary.

出版信息

Biomolecules. 2020 Nov 20;10(11):1581. doi: 10.3390/biom10111581.

Abstract

The Blm10/PA200 family of proteasome activators modulates the peptidase activity of the core particle (20S CP). They participate in opening the 20S CP gate, thus facilitating the degradation of unstructured proteins such as tau and Dnm1 in a ubiquitin- and ATP-independent manner. Furthermore, PA200 also participates in the degradation of acetylated histones. In our study, we use a combination of yeast and human cell systems to investigate the role of Blm10/PA200 in the degradation of N-terminal Huntingtin fragments (N-Htt). We demonstrate that the human PA200 binds to N-Htt. The loss of Blm10 in yeast or PA200 in human cells results in increased mutant N-Htt aggregate formation and elevated cellular toxicity. Furthermore, Blm10 in vitro accelerates the proteasomal degradation of soluble N-Htt. Collectively, our data suggest N-Htt as a new substrate for Blm10/PA200-proteasomes and point to new approaches in Huntington's disease (HD) research.

摘要

Blm10/PA200 蛋白酶体激活剂家族调节核心颗粒(20S CP)的肽酶活性。它们参与打开 20S CP 门,从而以不依赖泛素和 ATP 的方式促进 tau 和 Dnm1 等无结构蛋白质的降解。此外,PA200 还参与乙酰化组蛋白的降解。在我们的研究中,我们使用酵母和人类细胞系统的组合来研究 Blm10/PA200 在 N 端亨廷顿片段(N-Htt)降解中的作用。我们证明人类 PA200 与 N-Htt 结合。酵母中 Blm10 的缺失或人类细胞中 PA200 的缺失导致突变型 N-Htt 聚集体形成增加和细胞毒性升高。此外,Blm10 在体外加速可溶性 N-Htt 的蛋白酶体降解。总之,我们的数据表明 N-Htt 是 Blm10/PA200-蛋白酶体的新底物,并为亨廷顿病(HD)研究指出了新的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a15/7699873/c954db80d72e/biomolecules-10-01581-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验